PL2443232T3 - System heterologicznej ekspresji wirusowego białka w komórce gospodarza orzęska - Google Patents

System heterologicznej ekspresji wirusowego białka w komórce gospodarza orzęska

Info

Publication number
PL2443232T3
PL2443232T3 PL10724856T PL10724856T PL2443232T3 PL 2443232 T3 PL2443232 T3 PL 2443232T3 PL 10724856 T PL10724856 T PL 10724856T PL 10724856 T PL10724856 T PL 10724856T PL 2443232 T3 PL2443232 T3 PL 2443232T3
Authority
PL
Poland
Prior art keywords
host cell
viral protein
heterologous expression
ciliate host
ciliate
Prior art date
Application number
PL10724856T
Other languages
English (en)
Inventor
Marcus Hartmann
Christine Sachse
Jenny Apelt
Ulrike Bockau
Original Assignee
Cilian Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilian Ag filed Critical Cilian Ag
Publication of PL2443232T3 publication Critical patent/PL2443232T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/60—Vectors containing traps for, e.g. exons, promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL10724856T 2009-06-17 2010-06-15 System heterologicznej ekspresji wirusowego białka w komórce gospodarza orzęska PL2443232T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0910357A GB2471093A (en) 2009-06-17 2009-06-17 Viral protein expression in ciliates
EP10724856.9A EP2443232B1 (en) 2009-06-17 2010-06-15 System for the heterologous expression of a viral protein in a ciliate host cell

Publications (1)

Publication Number Publication Date
PL2443232T3 true PL2443232T3 (pl) 2017-08-31

Family

ID=40940892

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10724856T PL2443232T3 (pl) 2009-06-17 2010-06-15 System heterologicznej ekspresji wirusowego białka w komórce gospodarza orzęska

Country Status (11)

Country Link
US (1) US8377682B2 (pl)
EP (1) EP2443232B1 (pl)
JP (1) JP2012529899A (pl)
CN (2) CN102712909A (pl)
CA (1) CA2765799C (pl)
DK (1) DK2443232T3 (pl)
ES (1) ES2627402T3 (pl)
GB (1) GB2471093A (pl)
IN (1) IN2012DN00448A (pl)
PL (1) PL2443232T3 (pl)
WO (1) WO2010146043A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471093A (en) 2009-06-17 2010-12-22 Cilian Ag Viral protein expression in ciliates
EP2534264A4 (en) * 2010-02-09 2014-02-26 Univ Columbia METHOD FOR CHANGING A POLYPEPTIDE EXPRESSION AND SOLUBILITY
JP6841184B2 (ja) * 2017-08-07 2021-03-10 日立金属株式会社 半導体装置の製造方法
CN108130340B (zh) * 2018-02-06 2021-02-23 福建省农业科学院畜牧兽医研究所 表达鸭源禽流感病毒ns1蛋白的方法以及该方法的应用
CN114569710A (zh) * 2022-03-09 2022-06-03 华南农业大学 一种基于嗜热四膜虫tubulin蛋白的刺激隐核虫疫苗的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752473A (en) 1984-10-12 1988-06-21 The Regents Of The University Of California Expression of glycosylated human influenza hemagglutinin proteins
EP0670901A1 (en) * 1993-03-11 1995-09-13 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
US5762939A (en) * 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
EP1151104A1 (en) * 1999-02-04 2001-11-07 University Of Georgia Research Foundation, Inc. Diagnostic and protective antigen gene sequences of ichthyophthirius
EP1417218A4 (en) * 2001-07-13 2005-02-16 Univ Rochester TETRAHYMENA METALLOTHION IN GENE PROMOTER AND ITS USE
NZ533124A (en) * 2001-12-07 2005-11-25 Crucell Holland B Production of viruses, viral isolates and vaccines
WO2003078566A2 (en) * 2002-03-19 2003-09-25 Cilian Ag Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof
DE10214406A1 (de) * 2002-03-30 2003-10-09 Nutrinova Gmbh Verfahren und Marker zur einfachen Transformation und Selektion von rekombinanten Protisten
DE10214413A1 (de) * 2002-03-30 2003-10-09 Nutrinova Gmbh Expression von rekombinanten humanen Proteinen in Tetrahymena
WO2007006812A1 (en) * 2005-07-13 2007-01-18 Cilian Ag Tetrahymena heat inducible promoters and their use
CN101605558A (zh) * 2005-08-16 2009-12-16 夏威夷生物技术公司 流感重组亚单位疫苗
US20070286873A1 (en) * 2006-05-23 2007-12-13 Williams John V Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
BRPI0815662A2 (pt) * 2007-08-20 2016-09-27 Fraunhofer Usa Inc vacinas, antígenos, composições, e métodos profilácticos e terapêuticos para gripe
GB2471093A (en) 2009-06-17 2010-12-22 Cilian Ag Viral protein expression in ciliates

Also Published As

Publication number Publication date
GB2471093A (en) 2010-12-22
WO2010146043A2 (en) 2010-12-23
CA2765799A1 (en) 2010-12-23
IN2012DN00448A (pl) 2015-05-15
US20110008835A1 (en) 2011-01-13
GB0910357D0 (en) 2009-07-29
US8377682B2 (en) 2013-02-19
EP2443232B1 (en) 2017-03-01
CA2765799C (en) 2018-04-03
CN102712909A (zh) 2012-10-03
JP2012529899A (ja) 2012-11-29
ES2627402T3 (es) 2017-07-28
DK2443232T3 (en) 2017-05-22
CN107083393A (zh) 2017-08-22
EP2443232A2 (en) 2012-04-25
WO2010146043A3 (en) 2011-02-17
CN107083393B (zh) 2021-12-10

Similar Documents

Publication Publication Date Title
IL275846A (en) ACTRIIB–FC truncated fusion proteins
SG10201408129XA (en) Rna preparations comprising purified modified rna for reprogramming cells
PL2459702T3 (pl) Pożywka do hodowli komórkowej do ekspresji białka adamts
EP2226468B8 (en) Transonic blade
ZA201300147B (en) Recombinant host cells comprising phosphoketolases
EP3460064B8 (en) Efficient protein expression in vivo using modified rna (mod-rna)
HUE033138T4 (hu) Fehérje kinyerés
PL2406399T3 (pl) Białka mirac
PL2858489T3 (pl) Rekombinowane elementy dna do ekspresji rekombinowanych białek w komórce gospodarzu
ZA201204383B (en) Expression of hexose kinase in recombinant host cells
GB0908394D0 (en) Novel viral replication inhibitors
GB0913636D0 (en) Novel viral replication inhibitors
IL226501A (en) Transport of proteins from stem cell microcarriers
SI2462237T1 (sl) Postopki za izboljšanje ekspresije rekombinantnega proteina
PL2251257T3 (pl) Płetwa steru
PL2622078T3 (pl) Białko fuzyjne dla ekspresji białka wydzielniczego
EP2644616A4 (en) PROCESS FOR PRODUCING SPINDER CANVAS PROTEIN, FUSION PROTEIN, RECOMBINANT DNA, EXPRESSION VECTOR, HOST CELL, AND PRODUCTION STRAINS
EP2657337A4 (en) FUSION PROTEIN
SG10201401126QA (en) Method for polypeptide transfer into cells
PL2443232T3 (pl) System heterologicznej ekspresji wirusowego białka w komórce gospodarza orzęska
IL214620A0 (en) Methods for selecting eukaryotic cells expressing a heterologous protein
ZA201207425B (en) Fusion protein
ZA201201387B (en) Bovine herpesvirus vaccine
ZA201202432B (en) Identifying viral cell tropism
AU2024266827A1 (en) RNA preparations comprising purified modified RNA for reprogramming cells